Oneness Biotech Co., Ltd. Statistics
Oneness Biotech Co., Ltd. (4743) Stock Statistics & Valuation Metrics
Total Valuation
Oneness Biotech Co., Ltd. has a market cap or net worth of TWD 21.56B. The enterprise value is TWD 20.17B.
- Market Cap
- TWD 21.56B
- Enterprise Value
- TWD 20.17B
Share Statistics
Oneness Biotech Co., Ltd. has 480,548,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 480,548,500
- Owned by Insiders
- ―
- Owned by Institutions
- 3.88%
Financial Efficiency
Oneness Biotech Co., Ltd.’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -7.13%.
- Return on Equity (ROE)
- -0.10
- Return on Assets (ROA)
- -0.09
- Return on Invested Capital (ROIC)
- -7.13%
- Return on Capital Employed (ROCE)
- -0.07
- Revenue Per Employee
- 717.35K
- Profits Per Employee
- -5.80M
- Employee Count
- 180
- Asset Turnover
- 0.01
- Inventory Turnover
- 0.84
Valuation Ratios
The current PE Ratio of Oneness Biotech Co., Ltd. is 361.05. Oneness Biotech Co., Ltd.’s PEG ratio is 1.56.
- PE Ratio
- 361.05
- PS Ratio
- 150.70
- PB Ratio
- 2.17
- Price to FCF
- -118.04
- Price to Operating Cash Flow
- -127.54
- PEG Ratio
- 1.56
Income Statement
In the last 12 months, Oneness Biotech Co., Ltd. had revenue of 129.12M and earned -1.04B in profits. Earnings per share was -2.18.
- Revenue
- 129.12M
- Gross Profit
- 35.95M
- Operating Income
- -803.01M
- Pretax Income
- -1.06B
- Net Income
- -1.04B
- EBITDA
- -469.09M
- Earnings Per Share (EPS)
- -2.18
Cash Flow
In the last 12 months, operating cash flow was -174.55M and capital expenditures -15.96M, giving a free cash flow of -190.51M billion.
- Operating Cash Flow
- -174.55M
- Free Cash Flow
- -190.51M
- Free Cash Flow per Share
- -0.40
Dividends & Yields
Oneness Biotech Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -0.85%
- Earnings Yield
- 0.27%
Stock Price Statistics
- Beta
- 0.63
- 52-Week Price Change
- -26.31%
- 50-Day Moving Average
- 46.27
- 200-Day Moving Average
- 50.57
- Relative Strength Index (RSI)
- 42.45
- Average Volume (3m)
- 1.35M
Important Dates
Oneness Biotech Co., Ltd. upcoming earnings date is Feb 19, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Feb 19, 2027
- Ex-Dividend Date
- ―
Financial Position
Oneness Biotech Co., Ltd. as a current ratio of 11.81, with Debt / Equity ratio of 3.59%
- Current Ratio
- 11.81
- Quick Ratio
- 11.60
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 2.75
- Interest Coverage Ratio
- -90.22
Taxes
In the past 12 months, Oneness Biotech Co., Ltd. has paid 3.46M in taxes.
- Income Tax
- 3.46M
- Effective Tax Rate
- -0.00
Enterprise Valuation
Oneness Biotech Co., Ltd. EV to EBITDA ratio is -81.20, with an EV/FCF ratio of -116.99.
- EV to Sales
- 149.36
- EV to EBITDA
- -81.20
- EV to Free Cash Flow
- -116.99
- EV to Operating Cash Flow
- -127.69
Balance Sheet
Oneness Biotech Co., Ltd. has TWD 5.43B in cash and marketable securities with TWD 352.21M in debt, giving a net cash position of TWD 5.08B billion.
- Cash & Marketable Securities
- TWD 5.43B
- Total Debt
- TWD 352.21M
- Net Cash
- TWD 5.08B
- Net Cash Per Share
- TWD 10.57
- Tangible Book Value Per Share
- TWD 20.02
Margins
Gross margin is 38.44%, with operating margin of -528.29%, and net profit margin of 39.97%.
- Gross Margin
- 38.44%
- Operating Margin
- -528.29%
- Pretax Margin
- 53.68%
- Net Profit Margin
- 39.97%
- EBITDA Margin
- -183.94%
- EBIT Margin
- -402.55%
Analyst Forecast
The average price target for Oneness Biotech Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 37.17%
- EPS Growth Forecast
- ―
